Primary Election Results Signal Potential Shifts in Congressional Health Policy Leadership
Ahead of the Nov. 3 midterm elections, primary races across the country are already reshaping the outlook for the 120th Congress that begins in January 2027.
In several districts that are solidly held by Democrats, progressive candidates won June and July primaries, making them the likely winners in the November general election. Because these contests effectively determine who will hold those seats, the results will likely influence the priorities, leadership dynamics and policy agenda of the next Congress.
One of the most consequential primary elections for Democrats was in Colorado’s First Congressional District, which covers a large portion of the city and county of Denver. Political newcomer Melat Kiros defeated long-time incumbent Representative Diana DeGette. Over nearly three decades in the House, Rep. DeGette became a leading voice on health policy, including her work on landmark legislation such as the 21st Century Cures Act, which sought to accelerate medical innovation, strengthen research and improve patient access to new treatments.
Rep. DeGette’s loss raises questions about which member may step into the role of top Democrat on the powerful Energy & Commerce Committee. Rep. Raul Ruiz, MD (D-CA), a physician and current member of the committee, is among the names being discussed as a potential successor. Regardless of who succeeds Rep. DeGette, the transition will reshape how the biomedical and health policy advocacy community engages with the Energy & Commerce Committee, as stakeholders work to build relationships with new leaders and understand their policy priorities.
RSNA will continue to monitor election developments and assess how changes in congressional leadership could affect the Society’s policy priorities.
House AI Legislative Package Highlights Federal Focus on AI Standards, Data and Workforce
The House Science, Space, and Technology Committee has advanced a package of 10 AI bills. Collectively, the package is aimed at strengthening federal AI research, standards, security, education and workforce development.
Several of the measures would expand the role of the National Institute of Standards and Technology (NIST) in AI governance, including efforts to assess national and economic security risks, create voluntary guidelines for AI-ready federal data and develop model documentation templates. Other bills would support AI research infrastructure through the National Artificial Intelligence Research Resource (NAIRR), improve AI education and literacy, create interdisciplinary AI fellowships and develop a national framework for AI workforce competencies.
Although the House Science Committee does not have direct jurisdiction over health policy or biomedical research, the package has important implications for radiology and health AI. Together, the bills reflect growing congressional interest in the policy foundations needed for trustworthy AI adoption, including reliable standards, high-quality data, transparency, workforce readiness and mechanisms for identifying and reporting AI flaws.
These issues closely align with RSNA’s AI policy priorities as policymakers consider how federal standards and research infrastructure can support the safe, effective and clinically meaningful use of AI in patient care. RSNA will continue to monitor these developments and provide resources to members of Congress working on AI issues that are important to radiology and patient care.